Most intriguingly, recent findings suggest SLFN11’s involvement in immune regulation, particularly in promoting T-cell infiltration and activation in breast cancer, underscoring its multifaceted role in both cancer therapy and immune modulation (Isnaldi et al., 2019). Here, SLFN11 is linked to cancer.